Gilder Gagnon Howe & Co’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,389
Closed -$882K 285
2024
Q1
$882K Buy
+18,389
New +$982K 0.01% 216
2023
Q4
Sell
-51,931
Closed -$3.4M 277
2023
Q3
$3.4M Sell
51,931
-38,138
-42% -$2.4M 0.05% 159
2023
Q2
$5.24M Sell
90,069
-247
-0.3% -$15.6K 0.07% 152
2023
Q1
$5.58M Buy
90,316
+23,912
+36% +$1.43M 0.09% 131
2022
Q4
$4.22M Sell
66,404
-25,750
-28% -$1.87M 0.08% 146
2022
Q3
$6.69M Buy
92,154
+2,360
+3% +$176K 0.12% 119
2022
Q2
$6.11M Buy
89,794
+58,005
+182% +$4.17M 0.11% 123
2022
Q1
$2.88M Sell
31,789
-79,735
-71% -$6.53M 0.03% 207
2021
Q4
$10.2M Sell
111,524
-105,373
-49% -$9.03M 0.06% 178
2021
Q3
$17.6M Sell
216,897
-6,380
-3% -$536K 0.09% 167
2021
Q2
$20.8M Buy
223,277
+696
+0.3% +$67.5K 0.1% 155
2021
Q1
$23.8M Buy
222,581
+20,145
+10% +$2.09M 0.13% 144
2020
Q4
$17.7M Buy
202,436
+58,737
+41% +$4.15M 0.09% 154
2020
Q3
$9.92M Sell
143,699
-59,424
-29% -$3.82M 0.06% 172
2020
Q2
$9.84M Buy
+203,123
New +$9.7M 0.08% 149

Other funds holding NARI

Gilder Gagnon Howe & Co's NARI Position: Q2 2024 in Review

Gilder Gagnon Howe & Co sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 18,389 shares — an estimated $882K sold.

Gilder Gagnon Howe & Co first reported a position in NARI in Q2 2020 and held it in 15 quarters. The position peaked at $23.8M in Q1 2021. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Gilder Gagnon Howe & Co reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 18,389 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $882K.
  • Gilder Gagnon Howe & Co first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Gilder Gagnon Howe & Co's Inari Medical, Inc. Common Stock position peaked at $23.8M in Q1 2021.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.